U.S. Markets closed

Theravance Announces Positive Results From Phase 2b Study 0091 With Its LAMA Candidate, TD-4208, for the Treatment of COPD

SOUTH SAN FRANCISCO, CA--(Marketwired - Sep 4, 2013) - Theravance, Inc. ( NASDAQ : THRX ) today announced positive topline results from a dose-ranging 7-day cross-over design Phase 2b study of TD-4208, an investigational long-acting muscarinic antagonist (LAMA), administered once-a-day as a nebulized aqueous solution in patients with moderate to severe chronic obstructive pulmonary disease (COPD). The primary efficacy endpoint in this study was change from baseline in trough FEV1 (forced expiratory volume in one second) at the end of Day 7.

"We are very pleased with the positive results of the Phase 2b study of TD-4208 in patients with COPD," said Mathai Mammen, M.D., Ph.D., Senior Vice President of Research and Early Clinical Development. "We are encouraged that we have identified doses of TD-4208 that provide clinically meaningful levels of bronchodilation, as well as lower doses that do not. Additionally, TD-4208 demonstrated a 24 hour profile consistent with a once-a-day regimen."

TD-4208 met the primary efficacy endpoint for all six doses studied (ranging from 22 mcg to 700 mcg), and demonstrated a statistically significant change versus placebo from baseline in trough FEV1. The dose of 175 mcg was identified as the lowest that demonstrated a clinically meaningful change in FEV1 versus placebo at trough of 114 mL (95% CI: 76,153).

Serial FEV1 measurements over 24 hours on Day 7 demonstrated comparable bronchodilation over the first (0-12 hours) and second (12-24 hours) 12-hour periods. TD-4208 demonstrated a low peak to trough ratio for TD-4208 consistent with a once-a-day dosing regimen. TD-4208 pharmacokinetics demonstrated low (sub-pharmacologic) and predictable systemic exposure following dosing.

All doses of TD-4208 were generally well tolerated in the study with rates of adverse events comparable to placebo. The most common adverse events were headache, cough, and dyspnoea. Review of laboratory panels revealed no abnormal trends. There were no placebo-adjusted increases in heart rate or any ECG parameter at any of the doses at any time point. In addition, there were no discontinuations from the study attributed to adverse events related to study drug. Three patients experienced serious adverse events: one on placebo and two on TD-4208 22 mcg, none of which were considered to be treatment related.

About the Phase 2b Study

The objectives of this randomized, double-blind, multicenter, placebo-controlled Phase 2b study were to evaluate the bronchodilatory effect, pharmacokinetics, safety and tolerability of multiple doses of TD-4208 in patients with moderate to severe COPD. Sixty-two patients were randomized to receive four of six doses of TD-4208 (22, 44, 88, 175, 350 or 700 mcg) and placebo once daily via a nebulizer during five 7-day study periods in an incomplete crossover study design. The primary endpoint of the study was change from baseline in trough forced expiratory volume in one second (FEV1) after the seventh dose of each treatment period. Secondary endpoints included measurements of FEV1: Peak and area under the curve from 0 to 24 hours (AUC 0-24), AUC 0-12, and AUC 12-24 after the seventh dose of each treatment period.

About TD-4208 and the LAMA Program

TD-4208 is an investigational inhaled, long-acting muscarinic antagonist (LAMA) discovered by Theravance through the application of multivalent design to muscarinic receptors in a drug discovery program dedicated to finding new medicines for respiratory diseases such as COPD and asthma. In preclinical studies, TD-4208 has demonstrated high specificity for muscarinic receptors, a long receptor half-life, sustained activity in the lung after inhalation, and minimal effects outside of the lung. In a previously reported Phase 2a study, doses of 350 and 700 mcg of nebulized TD-4208 demonstrated sustained bronchodilation over 24 hours and an onset of action similar to that of ipratropium, which was included as an active comparator. The goal of Theravance's nebulized LAMA program for respiratory disease is to develop a once-a-day inhaled medicine for COPD.

Conference Call and Webcast Information

Theravance has scheduled an analyst conference call to discuss this announcement today at 8:30 a.m. Eastern Daylight Time. Analysts who wish to participate in the live call by telephone, please dial (877) 837-3908 from the U.S., or (973) 890-8166 for international callers. Those interested in listening to the conference call live via the internet may do so by visiting Theravance's web site at www.theravance.com. To listen to the live call and to download the slide presentation, please go to Theravance's web site 15 minutes prior to its start to register, download, and install any necessary audio software.

A replay of the conference call will be available on Theravance's web site for 30 days through October 5, 2013. An audio replay will also be available through 11:59 p.m. Eastern Daylight Time on September 12, 2013 by dialing (855) 859-2056 from the U.S., or (404) 537-3406 for international callers, and entering confirmation code 53230412.

About Theravance

Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. Theravance is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. Theravance's key programs include: RELVAR™ ELLIPTA™ or BREO™ ELLIPTA™ (FF/VI), ANORO™ ELLIPTA™ (UMEC/VI) and MABA (Bifunctional Muscarinic Antagonist-Beta2 Agonist), each partnered with GlaxoSmithKline plc, and its oral Peripheral Mu Opioid Receptor Antagonist program. By leveraging its proprietary insight of multivalency to drug discovery, Theravance is pursuing a best-in-class strategy designed to discover superior medicines in areas of significant unmet medical need. For more information, please visit Theravance's web site at www.theravance.com.

THERAVANCE®, the Theravance logo, and MEDICINES THAT MAKE A DIFFERENCE® are registered trademarks of Theravance, Inc.

RELVAR™, BREO™, ANORO™ and ELLIPTA™ are trademarks of the GlaxoSmithKline group of companies. The use of the brand names ANORO™ and RELVAR™ has not yet been approved by any regulatory authority.

This press release contains and the conference call will contain certain "forward-looking" statements as that term is defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, statements relating to goals, plans, objectives and future events. Theravance intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Examples of such statements include statements relating to: plans for executing the separation of Theravance into two independent companies, the expected timing of the separation, expectations for the amount and estimated duration of the funding of Theravance Biopharma at the time of the separation, the strategies, plans and objectives of the two companies following the separation, expectations related to the staffing of the two companies, the timing, manner and amount of anticipated potential returns of capital to stockholders if the separation is consummated, the possible tax effects of the separation, the status and timing of clinical studies, data analysis and communication of results, the potential benefits and mechanisms of action of product candidates, the enabling capabilities of Theravance's approach to drug discovery and its proprietary insights, expectations for product candidates through development and commercialization, and the timing of seeking regulatory approval of product candidates. These statements are based on the current estimates and assumptions of the management of Theravance as of the date of this press release and the conference call and are subject to risks, uncertainties, changes in circumstances, assumptions and other factors that may cause the actual results of Theravance to be materially different from those reflected in the forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, among others, risks related to: delays in preparing audited financial statements for Theravance Biopharma, difficulties in effecting the registration of Theravance Biopharma as a public company, failure to obtain necessary consents from third parties, changes in the development or operations of Theravance prior to the separation that could affect the plans for the separation or the cash available for the initial funding of the independent companies, delays encountered in obtaining, or the failure to obtain, the receipt of a private letter ruling from the Internal Revenue Service (should Theravance seek to effect the separation on a tax-free basis), the anticipated separation of Theravance into two independent companies or the intended return of capital to stockholders, the potential that results from clinical or non-clinical studies indicate product candidates are unsafe or ineffective, Theravance's dependence on third parties to conduct Theravance's clinical studies, delays or failure to achieve regulatory approvals for product candidates, risks of collaborating with third parties to discover, develop and commercialize products and risks associated with establishing distribution capabilities for telavancin with appropriate technical expertise and supporting infrastructure. Other risks affecting Theravance are described under the heading "Risk Factors" contained in Theravance's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (SEC) on August 1, 2013 and the risks discussed in Theravance's other periodic filings with the SEC. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Theravance assumes no obligation to update its forward-looking statements.

(THRX-G)

  • Here are Warren Buffett's 15 biggest stock investments
    Finance
    Business Insider

    Here are Warren Buffett's 15 biggest stock investments

    Warren Buffett's just released his annual letter to Berkshire Hathaway shareholders, and it included a list of the biggest stock investments held by the company. Buffett reiterated his belief in investing in companies with solid underlying businesses. Warren Buffett's annual letter to Berkshire Hathaway shareholders was released early Saturday morning, and it included a list of the company's 15 biggest stock holdings as of the end of 2017.

  • Russian Olympian Who Wore an 'I Don't Do Doping' Slogan Shirt Just Failed Her Drug Test
    World
    Time

    Russian Olympian Who Wore an 'I Don't Do Doping' Slogan Shirt Just Failed Her Drug Test

    Nadezhda Sergeeva, pilot of the two-woman bobsled team representing the Olympic Athletes from Russia, proudly proclaimed her anti-doping stance when she appeared in a YouTube video wearing a sweatshirt with the slogan “I don’t do doping” stamped brightly across the front. The federation says that the bobsledder does not have a prescription for the drug.

  • These Companies Are Sticking By The NRA
    Business
    HuffPost

    These Companies Are Sticking By The NRA

    NRA officials have gone on the attack to rail against the “politicization” of a tragedy, and going so far as to suggest that members of the media “love mass shootings” because of the ratings they supposedly bring. Enterprise Holdings, which operates the rental car brands Enterprise, National and Alamo, says it will end its discount program for NRA members next month, along with Avis and Budget.

  • Here's the Average Length of Retirement. Will Your Money Last That Long?
    Lifestyle
    Motley Fool

    Here's the Average Length of Retirement. Will Your Money Last That Long?

    If you're financially savvy, you're diligently saving and investing for retirement. You're probably a little uneasy about it all, though, not knowing exactly how much you need and, therefore, how on- or off-track you are. Part of the problem is that you

  • General Electric Cuts $2.4 Billion Off S&P-Worst Pension Deficit
    Finance
    Bloomberg

    General Electric Cuts $2.4 Billion Off S&P-Worst Pension Deficit

    General Electric Co. trimmed its pension deficit by $2.4 billion as the manufacturer tackles the worst shortfall in corporate America. The company closed 2017 with $100.3 billion in obligations across its pension plans and $71.6 billion in assets. Pension funding has become a central issue for GE stakeholders concerned about how the beleaguered company will meet its obligations while dealing with severe cash-flow and earnings challenges.

  • In 1961 a Plane Crash Killed the Entire U.S. Figure Skating Team. Here's How the Tragic Legacy Lives On
    News
    Time

    In 1961 a Plane Crash Killed the Entire U.S. Figure Skating Team. Here's How the Tragic Legacy Lives On

    Fifty-seven years ago this month, the U.S. figure skating team was devastated by a plane crash. The star-spangled athletes were on their way to compete at the 1961 World Figure Skating Championships in Prague, where they were expected to score medals and launch into preparations for the 1964 Olympics. The tragedy was mourned across the nation and shattered the figure skating world, which the U.S. had dominated for over a decade.

  • President Trump Went Way Off Script and Turned His CPAC Speech into a Campaign Rally
    Politics
    Time

    President Trump Went Way Off Script and Turned His CPAC Speech into a Campaign Rally

    When President Donald Trump took the stage at the Conservative Political Action Conference (CPAC) Friday morning, he clearly wanted to have some fun. For more than an hour, Trump held court, largely eschewing a teleprompter filled with prepared remarks on North Korea sanctions and remembrances for Billy Graham and the victims of the Parkland, Fla. shooting, instead choosing to ramble enthusiastically about familiar themes in his typical campaign style. Early in his CPAC speech, Trump caught a glimpse of himself in a TV monitor and joked, “I try like hell to hide the bald spot,” turning around to show the audience the back of his head.

  • Lisa Marie Presley Sues Manager for 'Reckless Mismanagement' of $100 Million Elvis Fortune
    Celebrity
    People

    Lisa Marie Presley Sues Manager for 'Reckless Mismanagement' of $100 Million Elvis Fortune

    Lisa Marie Presley and her financial manager Barry Siegel are in a legal battle after it was revealed that she’s $16.7 million in debt — Presley going after his “reckless and negligent mismanagement” of her inherited estate and Siegel claiming she “squandered” her own fortune due to her “excessive spending” habits. Much of that, she alleges, began in 2005 when Siegel sold 85 percent of her interest in Elvis Presley Enterprises in order to align himself with a famous investor tied to the holding company of American Idol. By 2016, Presley claims Siegel had liquidated almost all of the trust’s remaining principles — especially after the Idol holding company went bankrupt.

  • Democrats distance themselves from Nancy Pelosi
    Politics
    Fox Business Videos

    Democrats distance themselves from Nancy Pelosi

    Former President George W. Bush Deputy Assistant Brad Blakeman discusses why Democrats are starting to disengage from Senate Minority Leader Nancy Pelosi.

  • US asks judge to approve seizure of Pharma Bro's assets
    Finance
    Associated Press

    US asks judge to approve seizure of Pharma Bro's assets

    NEW YORK (AP) — "Pharma Bro" Martin Shkreli appeared in court Friday for the first time since a judge locked him up for his online antics, and the brash former pharmaceutical CEO had a new look since his bail was revoked in September: a scruffy beard that made his appearance less boyish. "Under the circumstances, I think he's doing remarkably well," his attorney, Ben Brafman, told reporters when asked about his client's stint in a fortress-like federal jail in Brooklyn. Shkreli was convicted on charges he cheated investors in two failed hedge funds.

  • This Las Vegas Airport Is Letting People Dump Their Marijuana Before Flying
    News
    Time

    This Las Vegas Airport Is Letting People Dump Their Marijuana Before Flying

    Tourists catching a flight out of Sin City can now dump their leftover legal marijuana in metal containers set up at the airport. The 10 green bins dubbed “amnesty boxes” prevent federal transportation agents from finding pot on passengers during security screenings. The containers were installed last week following a county ban on marijuana possession and advertising at McCarran International Airport, aiming to keep it in compliance with federal law.

  • Michael B. Jordan Had a Hilarious Response to an Internet Troll's Judgmental Opinion
    Celebrity
    Time

    Michael B. Jordan Had a Hilarious Response to an Internet Troll's Judgmental Opinion

    Michael B. Jordan’s charismatic turn as villain Erik Killmonger in Black Panther has commanded the collective attention of the Internet, some of who have taken it upon themselves to do extensive research into how Jordan lives his life off-camera, which has prompted a response from the actor himself. In an interview last year with Vogue, Jordan revealed that he shares a home with his parents and that he’d love to visit Tokyo, Japan because he loves anime, two facts that a Twitter user slyly pointed out might not be as endearing if they hadn’t come from the charming Fruitvale Station actor. As might be expected, the tweet went viral, catching the attention of Jordan himself, who had a pithy clap back to the tweet of his own.

  • Girl injured by dog during boarding for Southwest flight
    Lifestyle
    Associated Press

    Girl injured by dog during boarding for Southwest flight

    Southwest Airlines said Thursday that a dog injured a child as passengers boarded a flight in Phoenix, an event likely to fuel the debate over the growing number of emotional-support animals on planes. A passenger on Wednesday's Phoenix-to-Portland, Oregon, flight tweeted that a dog bit a girl as she approached it, and that she screamed and cried. Southwest said the dog's teeth "scraped a child's forehead" and paramedics checked the girl, who appeared to be 6 or 7 years old.

  • Dear America, here's how other countries stop mass shootings
    News
    Quartz

    Dear America, here's how other countries stop mass shootings

    Yesterday, Donald Trump met with a group of students, teachers, and parents to discuss last week’s school shooting massacre in Parkland, Florida and the uniquely American epidemic of school shootings. Referring to the shootings, Trump asked his guests, “Does anyone have any ideas for how to stop it?” The White House’s selected guests suggested a variety of areas to troubleshoot: Mental illness, bullying, FBI negligence, gun-free zones (which the president has publicly blamed for attracting “maniacs”), censorship, partisanship, lack of relatedness, obsession with identity, lack of expert “consultants,” lack of safety training for students, and even the absence of armed, undercover police in schools.

  • No Amazon Worries for FedEx
    Business
    barrons.com

    No Amazon Worries for FedEx

    Shares of FedEx (FDX) rose 2.77%, to $252.22, on Friday, thanks in part to an upgrade from Bernstein's David Vernon and his team. Vernon boosted his rating to Outperform and his price target to $290, writing that the shares are attractively valued and offer mid-teens earnings- per-share growth marking the "highest rate of return in company history," thanks to a strengthening global economy, rising interest rates, and strong business-to-consumer demand. Lower corporate taxes also figure into his thesis. It's the business-to-consumer part that may be most eye-catching for investors, as it's impossible to talk about shipping these days without talking about Amazon.com (AMZN). Vernon writes that

  • Hyundai Overtakes Its German Luxury Car Rivals
    Business
    Bloomberg Video

    Hyundai Overtakes Its German Luxury Car Rivals

    Feb.22 -- In its debut year, Hyundai’s luxury line bumped Volkswagen AG’s Audi from top billing to the No. 2 spot, with premium mainstays BMW, Toyota Motor Corp.’s Lexus and VW’s Porsche rounding out the top five. Bloomberg's Dave McCombs reports on "Bloomberg Daybreak: Asia."

  • 'We've Been Waiting for You.' Barack Obama Praises the Teen Shooting Survivors Fighting for Gun Control
    Politics
    Time

    'We've Been Waiting for You.' Barack Obama Praises the Teen Shooting Survivors Fighting for Gun Control

    Former President Barack Obama is throwing his support behind the teenagers vocally advocating for stricter gun control in the wake of the deadly Florida school shooting last week. “Young people have helped lead all our great movements,” Obama said on Twitter. Obama’s show of support came shortly before Wayne LaPierre, the National Rifle Association’s Executive Vice President, told the Conservative Political Action Conference Thursday that politicians and the media are exploiting the Florida school shooting to expand gun control and ultimately abolish the second amendment.

  • Canada's Trudeau spurs criticism, raises eyebrows on India trip
    World
    Reuters

    Canada's Trudeau spurs criticism, raises eyebrows on India trip

    By Andrea Hopkins and Nidhi Verma OTTAWA/NEW DELHI (Reuters) - Canadian and Indian officials scrambled on Thursday to explain how a convicted Sikh extremist was invited to a New Delhi reception for Justin Trudeau, the latest misstep in the Canadian prime minister's bumpy eight-day trip to India. The tour has been overshadowed by suggestions of a lukewarm reception by the government and a series of photo ops featuring the Trudeau family in coordinated Indian attire that have raised eyebrows in both countries. The latest flashpoint, a swiftly cancelled invitation by the Canadian delegation to Jaspal Atwal -- convicted in 1986 of the attempted murder of an Indian politician visiting Canada -- came just days after Trudeau had assured his hosts he would not support anyone trying to revive a separatist movement in India.

  • Citigroup to refund $335 million of credit card interest charges
    Business
    Reuters

    Citigroup to refund $335 million of credit card interest charges

    Citigroup Inc (C.N) said on Friday that it had failed to properly reduce interest charges on some 1.75 million credit card accounts since 2011, prompting a $335 million (239.65 million pounds) refund to customers later this year. The refund, which will average $190 per account, stems from the bank's discovery that it had not used a proper method for reducing interest charges for cardholders who resumed timely payments after having had to pay penalty rates for lapses. The errors amounted to about 10 percent of the interest reductions cardholders were due, the bank said.

  • Inside Tara Lipinski and Johnny Weir’s Rise From Olympic Figure Skaters to Beloved Commentators
    Celebrity
    Time

    Inside Tara Lipinski and Johnny Weir’s Rise From Olympic Figure Skaters to Beloved Commentators

    Tara Lipinski and Johnny Weir were bonding over their Céline bags while sitting outside of the NBC studios in Stamford, Connecticut, in 2013 when they had an idea. What if, they thought, they analyzed figure skating on camera at the upcoming 2014 Winter Olympics in Sochi together? Before that point, the two former Olympic figure skating stars had been preparing to commentate on the men’s and women’s events at the Games separately, both alongside NBC Sports’s Terry Gannon.

  • Why Nvidia (NVDA) Stock Is the Cheapest It's Been in Nearly a Year
    Finance
    Zacks

    Why Nvidia (NVDA) Stock Is the Cheapest It's Been in Nearly a Year

    It is no secret that Nvidia NVDA is one of Wall Street’s most popular stocks. The graphics chip maker is a dominant force in the global gaming industry, and its tireless investments in self-driving cars, machine learning, and artificial intelligence all but guarantee the company a spot among the tech industry’s leaders for years to come. Nvidia’s leadership and innovation have also led to a massive surge in the company’s stock.

  • GE says it may face U.S. action over subprime mortgage operations
    Business
    Reuters

    GE says it may face U.S. action over subprime mortgage operations

    General Electric Co (GE.N) faces potential action by the U.S. Justice Department over allegations that its GE Capital unit and now defunct WMC Mortgage Corp unit violated U.S. law in connection with subprime mortgages, according to a regulatory filing on Friday. GE said the department "is likely to assert" violation of the Financial Institutions Reform, Recovery, and Enforcement Act of 1989 (FIRREA) "in connection with WMC's origination and sale of subprime mortgage loans in 2006 and 2007," the filing said. "WMC and GE Capital will explore whether an acceptable settlement of this matter can be reached.

  • 3 Stocks That Feel Like Microsoft in 1986
    Business
    Motley Fool

    3 Stocks That Feel Like Microsoft in 1986

    Investors who bought into Microsoft's (NASDAQ: MSFT) growth story early and held on for the long term minted themselves an absolute fortune. Dan Caplinger (Match Group): There's nothing new about trying to find romance, but there's been a revolutionary change in the way that people seek out potential partners. Match Group has tapped into the needs of the mobile generation by extending its traditional online dating service to the app world, with its popular Tinder platform seeing its membership rolls nearly double in 2017 to 3.1 million members.

  • Broward Sheriff Deputy Resigns After Video Shows He Avoided School Shooting
    News
    Time

    Broward Sheriff Deputy Resigns After Video Shows He Avoided School Shooting

    The Broward sheriff deputy assigned to Marjory Stoneman Douglas High School resigned on Thursday, about a week after a school shooting there that left 17 people dead. Scot Peterson, a school resource officer from the Broward County Sheriff’s office, waited outside the school building without ever going inside, sheriff Scott Israel said during a news conference on Thursday. “What I saw was a deputy arrive at the west side of building 12, take up a position, and he never went in,” Israel said Thursday, referring to the school building where the shooter went on his rampage.

  • MGM Resorts Struggles on the Las Vegas Strip
    Business
    Motley Fool

    MGM Resorts Struggles on the Las Vegas Strip

    Revenue was up 5.5% for MGM Resorts to $2.6 billion and net income jumped from $24.7 million a year ago to $1.4 billion, or $2.42 per share. Digging into the numbers, you get a picture of why MGM Resorts had an underwhelming quarter in what seemed to be a favorable operating environment. Revenue per available room was down 4.9% on the Las Vegas Strip, driven by high-end resorts like Bellagio, MGM Grand Las Vegas, and Mandalay Bay all having both lower average daily room rates and lower occupancy versus a year ago.